Login

Mike Speetzen, CEO of Polaris, joins 'Closing Bell: Overtime' to discuss investor day, earnings, and the state of the high-ticket consumer market. 00:10:00

Share On Facebook Share On Twitter

Marc Murnaghan - Polaris Renewable Energy Inc.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
CEO Peter Furukawa to Create Phygital Stores with Live Commerce to Attract Consumers to Lojas Quero-Quero | Peter Furukawa, CEO, Lojas Quero-Quero SA.
00:10:00
The Money Couple: Scott and Bethany Palmer on Building Financial Intimacy in Marriage
00:10:00
A Journey from Sri Lanka to U.S. Diplomacy|David Arulanantham
00:10:00
Jean Salata on Private Equity Outlook and Strategic Investments | Jean Salata, CEO, Baring Private Equity Asia Ltd.
00:10:00
Highland Copper: U.S. Copper Projects and Growth Strategy Presentation.
00:10:00
Abhishek Bansal on the Positive Impact of Extended Derivatives Market Timings | Abhishek Bansal , CEO , Abans Holdings Ltd.
00:10:00
Transforming the Lithium Recycling Landscape: A Journey from Exploration to Innovation | Ajay Kochhar, CEO, Li-Cycle Holdings Corp.
00:10:00
Live from the Canaccord Adams Global Growth Conference in Boston, MA: An interview with LivePerson President/CEO Timothy Bixby on "Taking Stock."
00:10:00
Revolutionizing Subsurface Investigations with Electrical Resistivity Imaging
00:10:00
Cerrado Gold Corporate Presentation Highlights
00:10:00
Nick Bolton, CEO of Oxford Metrics, discusses the company's earnings and growth in augmented and virtual reality technologies.|Imogen was appointed CEO of Oxford Metrics
00:10:00
Investors should hold stocks for the next couple of years, says Simen Teigre, CEO of Pexip, reflecting on the company's successful year.

© 2017 - Neuhu+